Cargando...
Regular treatment with formoterol for chronic asthma: serious adverse events
BACKGROUND: Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe. OBJECTIVES: The aim of this review is...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017186/ https://ncbi.nlm.nih.gov/pubmed/22513944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006923.pub3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|